STAT3d
Risk of aspiration during surgery added to GLP-1 drug labels
The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...
FiercePharma22d
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Final results from the trials will be presented at upcoming medical conferences and will be submitted to regulators to support potential label updates, GSK added. Despite the nods from the FDA for ...
GlobalData on MSN22d
FDA expands Pfizer’s RSV vaccine label to include all high-risk adults
The label expansion adds to the existing label for ... Abrysvo’s main competitor is GSK’s Arexvy, which is approved in the ...
Business Wire22d
New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease
About the trial designs NCT06389487 is a phase IIIb open-label study to evaluate the non-inferiority of the immune response and to evaluate the safety of the GSK’s RSV vaccine in adults aged 18 ...